Capricor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CEOLinda Marbán
CEOLinda Marbán
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1996
Founded1996
Employees160
Employees160
CAPR Key Statistics
Market cap1.36B
Market cap1.36B
Price-Earnings ratio-16.66
Price-Earnings ratio-16.66
Dividend yield—
Dividend yield—
Average volume8.43M
Average volume8.43M
High today$40.37
High today$40.37
Low today$6.79
Low today$6.79
Open price$30.00
Open price$30.00
Volume56.96M
Volume56.96M
52 Week high$40.37
52 Week high$40.37
52 Week low$4.30
52 Week low$4.30
Stock Snapshot
With a market cap of 1.36B, Capricor(CAPR) trades at $27.20. The stock has a price-to-earnings ratio of -16.66.
As of 2025-12-04, Capricor(CAPR) stock has fluctuated between $6.79 and $40.37. The current price stands at $27.20, placing the stock +300.6% above today's low and -32.6% off the high.
Capricor(CAPR) shares are trading with a volume of 56.96M, against a daily average of 8.43M.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $4.30.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $4.30.
CAPR News
Benzinga 12h
Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To SayCapricor Therapeutics, Inc. (NASDAQ:CAPR) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CAPR. This list is generated using Robinhood data, and it’s not a recommendation.